Summary
This 8-K filing is an amendment to a previous report concerning leadership changes at Quest Diagnostics Inc. (DGX). The primary update is regarding the compensation and transition arrangements for Stephen H. Rusckowski, the current Chairman, CEO, and President. Mr. Rusckowski is set to retire as CEO and President on November 1, 2022, and will transition to the role of Executive Chairman until March 31, 2023. His existing employment agreement will not be renewed as he steps down from his executive roles. However, his compensation for his continued service as Executive Chairman is expected to remain generally aligned with his 2022 compensation. This filing provides clarity on the financial implications of this executive transition for a key leadership figure, which is important for understanding executive compensation policies and leadership continuity.
Key Highlights
- 1Amendment to a previous Form 8-K report.
- 2Stephen H. Rusckowski to retire as CEO and President effective November 1, 2022.
- 3Mr. Rusckowski will transition to Executive Chairman until March 31, 2023.
- 4Mr. Rusckowski's existing employment agreement will not be renewed.
- 5Compensation for Mr. Rusckowski's Executive Chairman role to be generally aligned with his 2022 compensation.
- 6James E. Davis is appointed as the new CEO and President, effective November 1, 2022 (as previously reported).